Andrea Alonci

Messina, 98121, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Editorial expression of concern: Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Editorial expression of concern: Monocytes and lymphocytes as active participants in the pathogenesis of experimental shock.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: September 06, 2024

Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma.

Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma.

Journal: Archives of medical science : AMS

Published: July 28, 2019

Standardisation of minimal residual disease in multiple myeloma.

Standardisation of minimal residual disease in multiple myeloma.

Journal: European journal of cancer care

Published: June 01, 2017

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.

Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.

Journal: Cancer investigation

Published: December 21, 2016

Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.

Possible Role of Interleukin-31/33 Axis in Imatinib Mesylate-Associated Skin Toxicity.

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: August 29, 2015

The cancer stem cell hypothesis: a guide to potential molecular targets.

The cancer stem cell hypothesis: a guide to potential molecular targets.

Journal: Cancer investigation

Published: September 26, 2014

Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.

Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura.

Journal: European journal of haematology

Published: April 13, 2014

MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.

MiRNome expression is deregulated in the peripheral lymphoid compartment of multiple myeloma.

Journal: British journal of haematology

Published: November 12, 2013

New orally active proteasome inhibitors in multiple myeloma.

New orally active proteasome inhibitors in multiple myeloma.

Journal: Leukemia research

Published: August 19, 2013

Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.

Reduction in IL-33 plasma levels might be involved in T cell dysregulation in chronic lymphocytic leukemia.

Journal: Acta haematologica

Published: May 13, 2013

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.

Journal: European journal of haematology

Published: March 13, 2013

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia.

Decreased plasma levels of IL-33 could contribute to the altered function of Th2 lymphocytes in patients with polycythemia vera and essential thrombocythemia.

Journal: Cancer investigation

Published: February 14, 2013

Showing 1-12 of 24

Last Updated: 09/26/2026